| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
-Subunit Expression Suppresses the Transformed Phenotype of Cells Overexpressing the Protein1 Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania and 2 Department of Cell Biology, Harvard Medical School, Boston, Massachusetts
Requests for reprints: Scot R. Kimball, Department of Cellular and Molecular Physiology, The Pennsylvania State College of Medicine, P.O. Box 850, Hershey, PA 17033. Phone: 717-531-8970; Fax: 717-531-7667; E-mail: skimball{at}psu.edu.
Key Words: eIF2B5 transformation shRNA siRNA
Eukaryotic initiation factor 2B (eIF2B), a five-subunit guanine nucleotide exchange factor, plays a key role in the regulation of mRNA translation. Expression of its
-subunit is specifically up-regulated in certain conditions associated with increased cell growth. Therefore, the purpose of the present study was to examine the effect of repressing eIF2B
expression on growth rate, protein synthesis, and other characteristics of two tumorigenic cell lines that display up-regulated expression of the
-subunit. Experiments were designed to compare spontaneously transformed fibroblasts to transformed mouse embryonic fibroblasts infected with a lentivirus containing a short hairpin RNA directed against eIF2B
. Cells expressing the short hairpin RNA displayed a reduction in eIF2B
abundance to 30% of the value observed in uninfected transformed mouse embryonic fibroblasts, with no change in the expression of any of the other four subunits. The repression of eIF2B
expression was accompanied by reductions in guanine nucleotide exchange factor activity and global rates of protein synthesis. Moreover, repressed eIF2B
expression led to marked reductions in cell growth rate in culture, colony formation in soft agar, and tumor progression in nude mice. Similar results were obtained in MCF-7 human breast cancer cells in which eIF2B
expression was repressed through transient transfection with a small interfering RNA directed against the
-subunit. Overall, the results support a role for eIF2B
in the regulation of cell growth and suggest that it might represent a therapeutic target for the treatment of human cancer. [Cancer Res 2008;68(21):8752–60]
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |